Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metolazone-induced cholestatic liver disease.
Gabrielli M, Gasbarrini A, Santoliquido A, Flore R, Gaetani E, Flex A, Pola P. Gabrielli M, et al. Dig Liver Dis. 2001 Aug-Sep;33(6):501. doi: 10.1016/s1590-8658(01)80029-3. Dig Liver Dis. 2001. PMID: 11572578 No abstract available.
COVID-19 and intestinal inflammation: Role of fecal calprotectin.
Ojetti V, Saviano A, Covino M, Acampora N, Troiani E, Franceschi F; GEMELLI AGAINST COVID‐19 group. Ojetti V, et al. Dig Liver Dis. 2020 Nov;52(11):1231-1233. doi: 10.1016/j.dld.2020.09.015. Epub 2020 Sep 22. Dig Liver Dis. 2020. PMID: 33060042 Free PMC article. No abstract available.
Raynaud's phenomenon and celiac disease.
Gabrielli M, Candelli M, Santarelli L, Nista EC, Santoliquido A, Gasbarrini G, Pola P, Gasbarrini A. Gabrielli M, et al. Am J Gastroenterol. 2003 Nov;98(11):2578-9. doi: 10.1111/j.1572-0241.2003.08680.x. Am J Gastroenterol. 2003. PMID: 14638377 No abstract available.
Probiotics in antibiotic-associated diarrhoea.
Cremonini F, Di Caro S, Santarelli L, Gabrielli M, Candelli M, Nista EC, Lupascu A, Gasbarrini G, Gasbarrini A. Cremonini F, et al. Among authors: gabrielli m. Dig Liver Dis. 2002 Sep;34 Suppl 2:S78-80. doi: 10.1016/s1590-8658(02)80171-2. Dig Liver Dis. 2002. PMID: 12408447
Probiotics and Helicobacter pylori eradication.
Canducci F, Cremonini F, Armuzzi A, Di Caro S, Gabrielli M, Santarelli L, Nista E, Lupascu A, De Martini D, Gasbarrini A. Canducci F, et al. Among authors: gabrielli m. Dig Liver Dis. 2002 Sep;34 Suppl 2:S81-3. doi: 10.1016/s1590-8658(02)80172-4. Dig Liver Dis. 2002. PMID: 12408448
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.
Lauritano EC, Gabrielli M, Lupascu A, Santoliquido A, Nucera G, Scarpellini E, Vincenti F, Cammarota G, Flore R, Pola P, Gasbarrini G, Gasbarrini A. Lauritano EC, et al. Among authors: gabrielli m. Aliment Pharmacol Ther. 2005 Jul 1;22(1):31-5. doi: 10.1111/j.1365-2036.2005.02516.x. Aliment Pharmacol Ther. 2005. PMID: 15963077 Clinical Trial.
Helicobacter pylori infection and vascular diseases.
Gasbarrini A, Serricchio M, Tondi P, Franceschi F, Ojetti V, Sanz Torre E, Candelli M, Gabrielli M, Fiore G, Pola R, Santoliquido A, Giacovazzo M, Gasbarrini G, Pola P. Gasbarrini A, et al. Among authors: gabrielli m. Ital J Gastroenterol Hepatol. 1998 Oct;30 Suppl 3:S307-9. Ital J Gastroenterol Hepatol. 1998. PMID: 10077761 Review.
421 results